HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.

Abstract
Melioidosis is a tropical bacterial infection caused by Burkholderia pseudomallei (B. pseudomallei; Bpm), a Gram-negative bacterium. Current therapeutic options are largely limited to trimethoprim-sulfamethoxazole and β-lactam drugs, and the treatment duration is about 4 months. Moreover, resistance has been reported to these drugs. Hence, there is a pressing need to develop new antibiotics for Melioidosis. Inhibition of enoyl-ACP reducatase (FabI), a key enzyme in the fatty acid biosynthesis pathway has shown significant promise for antibacterial drug development. FabI has been identified as the major enoyl-ACP reductase present in B. pseudomallei. In this study, we evaluated AFN-1252, a Staphylococcus aureus FabI inhibitor currently in clinical development, for its potential to bind to BpmFabI enzyme and inhibit B. pseudomallei bacterial growth. AFN-1252 stabilized BpmFabI and inhibited the enzyme activity with an IC50 of 9.6 nM. It showed good antibacterial activity against B. pseudomallei R15 strain, isolated from a melioidosis patient (MIC of 2.35 mg/L). X-ray structure of BpmFabI with AFN-1252 was determined at a resolution of 2.3 Å. Complex of BpmFabI with AFN-1252 formed a symmetrical tetrameric structure with one molecule of AFN-1252 bound to each monomeric subunit. The kinetic and thermal melting studies supported the finding that AFN-1252 can bind to BpmFabI independent of cofactor. The structural and mechanistic insights from these studies might help the rational design and development of new FabI inhibitors.
AuthorsKrishnamurthy Narasimha Rao, Anirudha Lakshminarasimhan, Sarah Joseph, Swathi U Lekshmi, Ming-Seong Lau, Mohammed Takhi, Kandepu Sreenivas, Sheila Nathan, Rohana Yusof, Noorsaadah Abd Rahman, Murali Ramachandra, Thomas Antony, Hosahalli Subramanya
JournalProtein science : a publication of the Protein Society (Protein Sci) Vol. 24 Issue 5 Pg. 832-40 (May 2015) ISSN: 1469-896X [Electronic] United States
PMID25644789 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Protein Society.
Chemical References
  • API 1252
  • Anti-Bacterial Agents
  • Benzofurans
  • Pyrones
  • Enoyl-(Acyl-Carrier-Protein) Reductase (NADH)
Topics
  • Anti-Bacterial Agents (chemistry, therapeutic use)
  • Benzofurans (chemistry, therapeutic use)
  • Burkholderia pseudomallei (drug effects, enzymology)
  • Crystallography, X-Ray
  • Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) (antagonists & inhibitors, chemistry, metabolism)
  • Humans
  • Kinetics
  • Melioidosis (drug therapy, enzymology, microbiology)
  • Pyrones (chemistry, therapeutic use)
  • Staphylococcal Infections (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: